Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical GRT6010 in bladder pain syndrome
2016-003940-35Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) comparing GRT6010 intravesical arm with Placebo intravesical arm (2 arms). Primary endpoint: Change in average daily pain scores. Started Jan 2017; status: completed.
02
Drugs
GRT6010
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2016-003940-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003940-35.